India
· Delayed Price · Currency is INR NSE:INDRAMEDCO Statistics
Total Valuation
NSE:INDRAMEDCO has a market cap or net worth of INR 34.75 billion. The enterprise value is 31.99 billion.
| Market Cap | 34.75B |
| Enterprise Value | 31.99B |
Important Dates
The next estimated earnings date is Wednesday, May 21, 2025.
| Earnings Date | May 21, 2025 |
| Ex-Dividend Date | Sep 13, 2024 |
Share Statistics
NSE:INDRAMEDCO has 91.67 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 91.67M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 2.90% |
| Owned by Institutions (%) | 7.32% |
| Float | 40.99M |
Valuation Ratios
The trailing PE ratio is 22.99.
| PE Ratio | 22.99 |
| Forward PE | n/a |
| PS Ratio | 2.60 |
| PB Ratio | 6.63 |
| P/TBV Ratio | 6.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 21.16 |
| EV / Sales | 2.39 |
| EV / EBITDA | 13.97 |
| EV / EBIT | 16.93 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | n/a |
| Interest Coverage | 56.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 24.18% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.49M |
| Profits Per Employee | 507,726 |
| Employee Count | 2,977 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +54.39% in the last 52 weeks. The beta is 0.72, so NSE:INDRAMEDCO's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +54.39% |
| 50-Day Moving Average | 383.80 |
| 200-Day Moving Average | 416.87 |
| Relative Strength Index (RSI) | 41.34 |
| Average Volume (20 Days) | 166,484 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:INDRAMEDCO had revenue of INR 13.37 billion and earned 1.51 billion in profits. Earnings per share was 16.49.
| Revenue | 13.37B |
| Gross Profit | 7.74B |
| Operating Income | 1.89B |
| Pretax Income | 2.03B |
| Net Income | 1.51B |
| EBITDA | 2.26B |
| EBIT | 1.89B |
| Earnings Per Share (EPS) | 16.49 |
Balance Sheet
The company has 3.09 billion in cash and 327.40 million in debt, giving a net cash position of 2.77 billion or 30.17 per share.
| Cash & Cash Equivalents | 3.09B |
| Total Debt | 327.40M |
| Net Cash | 2.77B |
| Net Cash Per Share | 30.17 |
| Equity (Book Value) | 5.24B |
| Book Value Per Share | 57.27 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 57.87%, with operating and profit margins of 14.13% and 11.30%.
| Gross Margin | 57.87% |
| Operating Margin | 14.13% |
| Pretax Margin | 15.15% |
| Profit Margin | 11.30% |
| EBITDA Margin | 16.89% |
| EBIT Margin | 14.13% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 1.18%.
| Dividend Per Share | 4.50 |
| Dividend Yield | 1.18% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 1.18% |
| Earnings Yield | 4.35% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |